Filing metadata

Accession number
0000899243-23-012347
Form type
Form 4
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
May 05, 2023
Reporting period
Apr 28, 2023
Description
Insider transaction

Explore SEC Filings Hub